Lexaria Bioscience Corp. Revolutionizes Drug Delivery for Type 2 Diabetes Treatment
Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently announced an exciting breakthrough in drug delivery technology, elevating the efficacy and delivery of GLP-1 agonists through its proprietary platform. The company s...
Jan 9, 2024
• Major Pharmaceutical Preparations Industry
Management Announcement
Lexaria Bioscience Corp.